Vistagen Therapeutics
Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

$65.8M

Market Cap • 4/3/2025

1998

(27 years)

Founded

2009

(16 years ago)

IPO

NASDAQ

Listing Exchange

Flag of US

South San Francisco

Headquarters • California